OHSU

OHSU Knight Cancer Institute News

The OHSU Knight Cancer Institute receives international, regional and local media coverage.

shaking handsOregon business groups, unions team up to raise funds for Knight Cancer Challenge SEPTEMBER 2014

Seven Oregon business and labor organizations have teamed up to form Unite for the Knight, a coalition to build support and raise money for the $1 billion Knight Cancer Challenge.

As featured in: ktvz kxl ktvz opb ktvz 

sunHigh Desert conditions lead to high skin cancer rates SEPTEMBER 2014

Oregon’s sunny High Desert region boasts some of the highest rates of skin cancer in the state. Sancy Leachman, M.D., Ph.D., head of melanoma research at the OHSU Knight Cancer Institute, weighed in on the conditions that lead to such high skin cancer rates and discusses which symptoms to watch for.

As featured in: ktvz

Beat-AMLAptose Biosciences Joins OHSU to Fight Deadly Form of Leukemia SEPTEMBER 2014

Aptose Biosciences joined the Beat AML collaboration, led by researchers at the OHSU Knight Cancer Institute. The multi-institutional research initiative aims to find treatments for acute myeloid leukemia (AML).

As featured in: go-local-pdx

On AirBrian Druker joins Live Wire SEPTEMBER 2014

OHSU Knight Cancer Institute Director Brian Druker, M.D., joined the season premiere of Live Wire, a Portland-based radio show that airs nationally. The show focused on trailblazers in their fields. Druker’s interview focused on his research that led to the once-a-day cancer pill Gleevec® and the plans he has to meet what he believes is most important unmet need in cancer care today.

As featured in: livewire

Gert Boyle'Your Voice, Your Vote:' Gert Boyle and her donation SEPTEMBER 2014

Gert Boyle, the chairwoman of Columbia Sportswear, discussed her $100 million donation to the OHSU Knight Cancer Institute with KATU.

As featured in: katu.com

Tomasz BeerFDA expands use of prostate cancer pill because of clinical trials led at Knight Cancer Institute SEPTEMBER 2014

Enzalutamide received federal approval based on OHSU Knight Cancer Institute clinical study showing it prolongs life, enables prostate cancer patients to delay chemotherapy.

As featured in: Oregonian KPTV yahoo biz journal

Dr. AmlingMen, if you’re 50, it’s time for a prostate exam AUGUST 2014

Christopher Amling, M.D., urologic cancer specialist with the OHSU Knight Cancer Institute, discussed the importance of prostate exams, the pros and cons of the screening and when to have a conversation about the exam with a physician.

As featured in: Pamplin media group

philanthropyColumbia Sportswear chairwoman revealed as $100-million donor AUGUST 2014

The OHSU Knight Cancer Institute received in July 2014 a $100-million gift from Gert Boyle, the chairwoman of Columbia Sportswear. She initially made the donation anonymously but later publicly confirmed her identity to encourage others to give.

As featured in: chronicles of philanthropy (1) chronicles of philanthropy (2) chronicles of philanthropy (1) chronicles of philanthropy (2) chronicles of philanthropy (3)chronicles of philanthropy 

bullseyeBioCentury: Transformative Medicine AUGUST 2014

Brian Druker, M.D., director of the OHSU Knight Cancer Institute, explained the science behind Gleevec and other targeted cancer drugs, which moved treatment from systemic and toxic therapies to life-saving approaches with specific targets.

As featured in: bio-century

400millionAnonymous $100 Million Gift Moves OHSU Within $82 Million of Reaching $1 Billion Goal AUGUST 2014

The OHSU Knight Cancer Institute moved one step closer to meeting a spectacular fundraising goal when it received a $100 million gift from an anonymous donor.

As featured in: the-cancer-letter

Unapproved DrugsWhen Unapproved Drugs are the Only Hope AUGUST 2014

Nathalie Traller was diagnosed in 2013 with a rare cancer that a new class of drugs may help combat. But, at 15 years old, she’s too young to qualify for the related clinical trials. Brian Druker, M.D., director of the OHSU Knight Cancer Institute and a major force behind development of the leukemia drug Gleevec, has adopted Nathalie’s case and is working with colleagues at the National Institutes of Health to explore possible options for her.

As featured in: cnbc

philanthropy$100-Million Gift Pushes Oregon University to Brink of Securing $500-Million Match JULY 2014

Oregon Health & Science University received a $100-million anonymous gift, which became part of a $1 billion fundraising drive for the Knight Cancer Institute that got a large dose of urgency from Phil and Penny Knight’s pledge.

As featured in: chronicles of philanthropy

100millionOHSU receives $100 million anonymous gift toward Knight Cancer Challenge JULY 2014

An anonymous donor gave $100 million to OHSU Knight Cancer Institute to help a fundraising challenge <link to www.onedown.org> ; the gift is one of the four largest pledges in OHSU’s history and is the largest private donation to the campaign to date.

As featured in: The Oregonian     The Oregonian    fox12     koin6    

tying-shoesPete Julian's race isn't over, but the Oregon Project coach is kicking cancer JULY 2014

Pete Julian, now an assistant coach with the Nike Oregon Project distance runners training group, was at a loss following his 2008 cancer surgery. Diagnosed with GIST, his third gastrointestinal surgery was only partially successful, leaving him with at least three tumors. When Dr. Michael Heinrich put him on a targeted therapy that OHSU’s Brian Druker helped develop, his tumors vanished.

As featured in: Oregonian

Private SciencePrivate Science JULY 2014

Private donors are playing an increasingly important role in the funding—and direction—of scientific research including at the OHSU Knight Cancer Institute.

As featured in: oregonBusiness

Brian Druker, M.D.How OHSU's Brian Druker Hopes to Cure Cancer January 2014

Brian Druker, M.D., director of OHSU’s Knight Cancer Institute, and OHSU President Joe Robertson, M.D., M.B.A., share insights on OHSU’s $200 million request for state support, the $1 billion Knight Cancer Challenge, and what OHSU will do with the billion dollars it is raising.

As featured in: Willamette Week

Can cancer be cured in the pacific northwest?Can cancer be cured in the Northwest? JULY 2014

Between Oregon Health & Science University’s Knight Cancer Institute, the University of Washington School of Medicine, and the Fred Hutchinson Cancer Research Center, the Pacific Northwest is becoming a cancer research hotbed.

As featured in: biz journal

letters_jumbledGrowing Participation in Novartis' Signature Program Bodes Well for Novel PGx Signal Finding Approach JULY 2014

Drug maker Novartis last year launched the Signature Program, a drug trial series in which patients are enrolled in mutation-specific study protocols that emphasize molecular pathways over tumor sites or histology. Oregon Health & Science University is among the institutions leading the program.

As featured in: genomeweb (Article available only to Genome Web subscribers)

smileOHSU's Knight Cancer Challenge bites off a $1M pledge JUNE 2014

Willamette Dental Group announced in June 2014 that it will contribute $1 million to the Knight Cancer Challenge. The group dental practice will match all contributions to the challenge in the next year, and then President and Chief Executive Officer Dr. Eugene Skourtes will match the combined total.

As featured in: biz journal

cynthia“Be the Match” search for a bone marrow transplant JUNE 2014

Cynthia Speckman, who was treated at the OHSU Knight Cancer Institute for chronic myeloid leukemia (CML ) appeared on KATU’s AM Northwest to talk about her diagnosis and search for a bone marrow transplant. She was joined by Be the Match spokesperson Kim Allen, who spoke about the organization and its efforts to help patients get marrow or cord blood transplants.

As featured in: katu.com

local emplyeesLocal employees join Knight Cancer Challenge JUNE 2014

Oregon companies have provided a huge boost to the $1 billion Knight Cancer Challenge since its announcement in September 2013. The Standard launched a year-long employee campaign in June 2014 to lend its support, vowing to raise more than $250,000 for the OHSU Knight Cancer Institute.

As featured in: KGW

labsOHSU's Druker spells out plans for early cancer detection team JUNE 2014

Brian Druker, M.D., director of the OHSU Knight Cancer Institute, told employees of The Standard that revolutionizing early cancer detection will be an integral part of Knight Cancer’s mission going forward. Druker was invited to speak to employees of The Standard as the company launched a campaign to raise funds for the $1 billion Knight Cancer Challenge.

As featured in: biz journal

Tanning Beds considered high-risk for skin cancer by FDAFDA: Tanning lamps now considered 'high-risk' MAY 2014

In an effort to reduce rising rates of skin cancer linked to tanning devices, the FDA announced that tanning beds and sun lamps must carry new warnings. The OHSU Knight Cancer Institute increased its advocacy for such restrictions in 2013 when it, among other things, campaigned in support  of Oregon passing a law restricting minors’ access to tanning beds.

As featured in: KGW

Sancy LeachmanOHSU doctor wages war on melanoma in Oregon MAY 2014

Sancy Leachman, M.D., Ph.D., who leads melanoma research at OHSU Knight Cancer Institute, recently launched a registry to create a network for advancing the treatment, prevention and detection of the disease.

As featured in: KGW

cloudsOregon's clouds no protection against melanoma: Guest opinion MAY 2014

An OHSU patient discusses his experiences with melanoma and promotes the new Community Melanoma Registry, set up by the OHSU Knight Cancer Institute, in a guest column penned for The Oregonian.

As featured in: Oregonian

286-millionOHSU reports $86 million in private donations for cancer research MARCH 2014

Donors have given Oregon Health & Science University’s Knight Cancer Institute about $86 million within six months toward a $500 million goal. When combined with $200 million in bonding approved by state lawmakers, the institute is well past the halfway mark in meeting a $500 million challenge from Nike co-founder Phil Knight. More than 3,700 donations and pledges came from 47 states; Washington, D.C.; and Canada.

As featured in: The Oregonian (1) The Oregonian (2) Chronicle of Philanthropy

dogCancer research for dogs could help children MARCH 2014

A Knight Cancer Institute doctor is looking for dogs with cancer for his research on treatment that could benefit children with bone cancer.

As featured in: KGW

big moneyWho are the biggest givers? And where do they get the money? FEBRUARY 2014

Big philanthropy returned in 2013, keyed in part by Nike co-founder Phil Knight and his wife Penelope Knight. The Knights kick started the Knight Cancer Challenge with a $500 million pledge, provided OHSU can raise matching funds within two years.

As featured in:marketplace

druker_lab Video - How OHSU's Brian Druker Hopes to Cure Cancer JANUARY 2014

Watch a video of Dr. Brian Druker at Willamette Week, discussing the opportunity to cure cancer with a $1.2 billion investment from private philanthropy as part of the Knight Cancer Challenge and state infrastructure support.

As featured in: willamette week

ResearchDrug Shows Promise in Advanced Prostate Cancer When Used Before Chemotherapy JANUARY 2014

The New York Times reports on potential broader use of Xtandi to treat prostate cancer following clinical trial conducted at the Knight Cancer Institute.

As featured in: US NEWS

older manDrug May Extend Survival for Men With Advanced Prostate Cancer JANUARY 2014

A recently released study suggests that a new hormone therapy may increase survival for men with advanced prostate cancer. HealthDay speaks with the Knight Cancer Institute’s deputy director, Tomasz Beer, M.D. about the implications for patients.

As featured in: US NEWS

jobs-career-work-opportunityOHSU's Knight Cancer Challenge to create more than 1K jobs, inject millions JANUARY 2014

The Portland Business Journal reports on how investing in cancer research will yield thousands of jobs, millions into local and state economy and help create a cancer-curing economy for Oregon.

As featured in: biz journal

astoriaEditorial: Knight gift to OHSU is worth more state money JANUARY 2014

The Daily Astorian weighs in with why the Knight gift to OHSU is worth more state money

As featured in: Daily Astorian

clinical_trials_scientist_dropperQ&A: Why OHSU wants $200 million from Oregon Legislature for cancer research JANUARY 2014

 A Q&A with an Oregonian capitol reporter explains how Oregon can support transformational cancer research and clinical trials as part of the Knight Cancer Challenge. 

As featured in: oregonian

eugeneApprove OHSU bonds: Oregon has a big stake in cancer institute JANUARY 2014

Read why the Eugene Register Guard supports the state providing capital bonding support for cancer research and patient care.

As featured in: Register Guard

joe-robertsonHow OHSU's Brian Druker Hopes to Cure Cancer JANUARY 2014

OHSU President Joe Robertson and Dr. Brian Druker sit in Willamette Week’s “Hot Seat” and answer questions about the Knight Cancer Challenge and Oregon’s opportunity to end cancer as we know it.

As featured in: Willamette Week

buildingOregon could sell $200 million in bonds for Phil and Penny Knight's $1 billion challenge for OHSU cancer research NOVEMBER 2013

Building on a record of success in partnerships, the Oregonian reports on $200 million in capital construction bonding OHSU is requesting for critical infrastructure to support cancer research and patient care/clinical trials.

As featured in: oregonian

Tim NesbittA challenge to energize Oregon NOVEMBER 2013

Tim Nesbitt, a columnist for The Oregonian, shares how the $1 billion Knight Cancer Challenge is an opportunity to take pride in the ingenuity of our scientists and the generosity of Oregonians.

As featured in: oregonian

MedicationMedivation cancer drug improves survival in wider use trial OCTOBER 2013

Reuters details results of a prostate cancer drug clinical trial, led by Knight Cancer Institute Deputy Director.

As featured in: Reuters

Who GivesWho Gives? OCTOBER 2013

The Knight Cancer Challenge is unprecedented for any fundraising campaign. It has the potential to transform philanthropy in Oregon and around the world.

As featured in: OPB - Think Out Loud
Editorial

Brian Druker in the labBillion Dollar Knight Cancer Challenge SEPTEMBER 2013

Dr. Brian Druker, talks about a billion research dollars.

As featured in: OPB - Think Out Loud

OHSU$1 BILLION HANGING IN THE BALANCE, KNIGHT CANCER INSTITUTE MUST SHOW ITS BEST SEPTEMBER 2013

An Oregonian editorial on the Knight Cancer Challenge.

As featured in: The Oregonian

$500M Pledge$500M Pledge SEPTEMBER 2013

Phil and Penny Knight pledge $500 million, if OHSU can match it.

As featured in: The Oregonian KGW.com News Channel 8 CNN Bloomberg USA TODAY Chronicle of Philanthropy AAAS Science Magazine

Learn more about OHSU Knight Cancer Institute from these sources:

Smithsonian on Brian Druker, M.D., director of the OHSU Knight Cancer Institute
New York Times on Brian Druker’s stance on cancer drug prices
New England Journal of Medicine documentary on Brian Druker’s impact on cancer research and treatment
Wall Street Journal review of book that chronicles the history of Brian Druker’s cancer research breakthrough
Wall Street Journal on Beat AML collaboration
Wall Street Journal on program for young adults with cancer
Portland Monthly on the OHSU Knight Cancer Institute’s cancer research vision
Intel Corporation’s president’s speech including segment on OHSU-Intel collaboration in cancer research

CBS affiliate documentary: Personalized Medicine: Ending Cancer as We Know It

The Oregonian on prostate cancer Dream Team
The Oregonian on breast cancer researcher Lisa Coussens
New York Times and Joe Gray
The Oregonian on the OHSU Knight Cancer Institute’s strategic vision
The Oregonian on the Knight Diagnostic Laboratories
Healthy Body, Healthy Mind on PBS, Treatment of Chronic Myeloid Leukemia
Healthy Body, Healthy Mind on PBS, Treatment of Gastrointestinal Stromal Tumor